Join us at the DCI Annual Scientific Retreat! We will be presenting a poster on the preclinical resource and will be available for questions/comments/suggestions.
The Duke Preclinical Translational Research Unit has received 3 years funding from the School of Medicine as a new Core Research Facility with approval from Raphael Valdivia, PhD, Vice Dean for Basic Science. We are grateful to Dr. Valdivia and the support from the SOM.
The Duke Preclinical Translational Research Unit has received funding support from the Duke Cancer Institute as a pilot shared resource. We are grateful to Michael Kastan, MD, PhD, Executive Director of the Duke Cancer Institute, and Mark Dewhirst, DVM, PhD, Director of the DCI Shared Resources Oversight Committee for their support.